MyFinsight
Home
Blog
About
Defen Cath
$66,119,000
Melinta Portfolio
$28,222,000
Product
$94,341,000
Contract Revenue
$4,966,000
Grant Income
$2,624,000
Total revenue and
grant income
$101,931,000
Gross profit
$77,126,000
Cost of sales
(exclusive of amortization...
$14,505,000
Amortization of intangibles
$10,300,000
Income from operations
$42,910,000
Total operating
expenses
$34,216,000
Income before income
taxes
$38,733,000
Total other (expense)
income
-$4,177,000
Unrealized gain (loss) on
marketable equity security
$2,546,000
General and
administrative
$15,085,000
Selling and marketing
$12,447,000
Research and development
$6,684,000
Net income
$25,988,000
Tax expense
$12,745,000
Change in contingent
consideration
-$6,652,000
Other non-operating
(expense) income, net
-$71,000
Back
Back
Income Statement
CorMedix Inc. (CRMD)
CorMedix Inc. (CRMD)
source: myfinsight.com